299 related articles for article (PubMed ID: 11325664)
1. Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer.
Franchini M; Capra F; Capelli C; de Maria E; Lippi G; Gandini G
Haematologica; 2001 Apr; 86(4):E12. PubMed ID: 11325664
[No Abstract] [Full Text] [Related]
2. Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII.
Koyama T; Nagao T; Tsunozaki H; Arai M; Miura O
Pathophysiol Haemost Thromb; 2006; 35(5):405-7. PubMed ID: 17230044
[No Abstract] [Full Text] [Related]
3. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.
Baudo F; de Cataldo F; Gaidano G;
Haematologica; 2004 Jun; 89(6):759-61. PubMed ID: 15194550
[TBL] [Abstract][Full Text] [Related]
4. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors.
Smith OP
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():22-5. PubMed ID: 12214142
[TBL] [Abstract][Full Text] [Related]
6. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
[No Abstract] [Full Text] [Related]
7. Effective treatment with recombinant factor VIIa of severe bleeding due to acquired factor VIII inhibitor and acquired thrombocytopathy.
Conesa V; Mompel A; Lopez F; Marín F; Ruiz J; Navarro F; Gomez A
Am J Hematol; 2002 Aug; 70(4):329-30. PubMed ID: 12210816
[No Abstract] [Full Text] [Related]
8. A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors.
Chuansumrit A; Sri-Udomporn N; Srimuninnimit V; Juntarukha R
Haemophilia; 2001 Sep; 7(5):532-4. PubMed ID: 11554948
[No Abstract] [Full Text] [Related]
9. Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors: a report of five cases.
Slaoui M; Lambert T; Stieltjes N; Claeyssens S; Borel-Derlon A;
Blood Coagul Fibrinolysis; 2004 Oct; 15(8):687-91. PubMed ID: 15613924
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors.
Ingerslev J
Semin Thromb Hemost; 2000; 26(4):425-32. PubMed ID: 11092219
[TBL] [Abstract][Full Text] [Related]
11. Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody.
Gringeri A; Santagostino E; Mannucci PM
Haemostasis; 1991; 21(1):1-4. PubMed ID: 1907588
[TBL] [Abstract][Full Text] [Related]
12. The concept of recombinant factor VIIa megadose for treating bleeding episodes in high-titer inhibitor patients with hemophilia: toward an expanding indication?
Negrier C
J Thromb Haemost; 2003 Mar; 1(3):423-4. PubMed ID: 12871444
[No Abstract] [Full Text] [Related]
13. Thrombelastography-guided factor VIIa therapy in a surgical patient with severe hemophilia and factor VIII inhibitor.
Pivalizza EG; Escobar MA
Anesth Analg; 2008 Aug; 107(2):398-401. PubMed ID: 18633014
[TBL] [Abstract][Full Text] [Related]
14. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
Levi M; Friederich PW; van der Meer J
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2534-7. PubMed ID: 12532665
[TBL] [Abstract][Full Text] [Related]
15. Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII.
Liebman HA; Chediak J; Fink KI; Galvez AG; Shah PC; Sham RL
Am J Hematol; 2000 Mar; 63(3):109-13. PubMed ID: 10679799
[TBL] [Abstract][Full Text] [Related]
16. [Ischemic colitis following the treatment of acute hemorrhage in a patient with acquired hemophilia A].
Suzuki T; Arai A; Koyama T; Oshikawa G; Yamamoto M; Mizuchi D; Kurosu T; Tohda S; Murakami N; Miki T; Miura O
Rinsho Ketsueki; 2006 Apr; 47(4):310-4. PubMed ID: 16715966
[TBL] [Abstract][Full Text] [Related]
17. Transfusion medicine service policies for recombinant factor VIIa administration.
Goodnough LT; Lublin DM; Zhang L; Despotis G; Eby C
Transfusion; 2004 Sep; 44(9):1325-31. PubMed ID: 15318856
[TBL] [Abstract][Full Text] [Related]
18. Dose optimization of recombinant factor VIIa in the treatment of acute bleeding in haemophilia-associated inhibitors.
Seremetis S
Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S29-30. PubMed ID: 14567532
[TBL] [Abstract][Full Text] [Related]
19. The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa.
Negrier C; Hay CR
Semin Thromb Hemost; 2000; 26(4):407-12. PubMed ID: 11092216
[TBL] [Abstract][Full Text] [Related]
20. Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery.
Biron-Andréani C; Dupeyron G; Mainemer M; Schved JF
Blood Coagul Fibrinolysis; 2001 Apr; 12(3):215-6. PubMed ID: 11414637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
